tridemorph has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bomben, R; Canzonieri, V; Colombatti, A; Danussi, C; Degan, M; Gattei, V; Perris, R; Radillo, O; Spessotto, P; Wasserman, B; Zucchetto, A | 1 |
1 other study(ies) available for tridemorph and Leukemia, Lymphocytic, Chronic, B-Cell
Article | Year |
---|---|
Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Cell Adhesion Molecules; Cell Movement; Female; Fibronectins; Gene Expression; Humans; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Immunohistochemistry; Integrin alpha3beta1; Kalinin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Mutation; Protein Isoforms; RNA, Messenger | 2007 |